Minerva Neuroscience
Clinical development of treatments for central nervous system disorders.
Launch date
Employees
Market cap
€18.8m
Enterprise valuation
(€9m) (Public information from Sep 2024)
Share price
$2.817 NERV
Waltham Massachusetts (HQ)
Authorizing premium user...